• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venmax Drugs & Pharmaceuticals Ltd Trading

  • Indian Private
  • BSE Code : 6161.0
  • ISIN : INE154G01022
13.99 -1 (-6.61%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    13.75

  • Today’s High

    15.90

  • Open

    15.00

  • Perv Close

    14.98

  • 52W Low

    12.71

  • 52W High

    31.49

Key Indicators

  • P/E(TTM)

    73.63

  • Mar.Cap (₹Cr.)

    20.26

  • Div & Yield %

    0.00

  • Book Value(₹)

    14.37

  • Debt-Equity Ratio

    -6.61

  • AGM Date

    22-Sep-2026

  • EPS

    0.19

  • P/E Ratio

    73.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    20.26

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.48

  • BV (₹)

    14.40

  • Sales( ₹ in Cr.)

    8.02

  • NP (in Cr.)

    0.25

  • NP Var(%)

    2464.0

  • Div%

    0.0

  • CPS (₹)

    0.20

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    20.26

  • 52 Week High

    31.49

  • 52 Week Low

    12.71

  • Price BSE

    14.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.26

  • P/C Ratio

    80.40

  • P/E Ratio

    81.70

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 8.02 0.81 0.00 0.00 0.00 0.17
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 8.02 0.81 0.00 0.00 0.00 0.17
Other Income 0.16 1.05 0.20 0.42 1.98 0.18
Stock Adjustments 0.94 0.06 0.00 0.00 0.00 -0.22
Total Income 9.12 1.92 0.20 0.42 1.98 0.13
EXPENDITURE :            
Raw Materials 8.22 0.85 0.00 0.00 0.00 0.08
Power and Fuel Cost 0.01 0.00 0.00 0.01 0.00 0.00
Employee Cost 0.20 0.04 0.02 0.03 0.01 0.06
Other Manufacturing Expenses 0.00 0.00 0.01 0.00 0.00 0.00
Selling and Administration Expenses 0.16 0.81 0.05 0.10 0.11 0.13
Miscellaneous Expenses 0.25 0.22 0.02 0.04 0.01 0.02
Employee Benefit Expenses 0.20 0.04 0.02 0.03 0.01 0.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8.84 1.92 0.10 0.19 0.13 0.29
Operating Profit 0.28 -0.01 0.09 0.23 1.86 -0.15
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.28 -0.01 0.09 0.23 1.86 -0.15
Depreciation 0.00 0.01 0.01 0.01 0.01 0.01
Profit Before Tax 0.28 -0.02 0.08 0.22 1.85 -0.16
Current Tax 0.03 0.00 0.02 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.25 -0.01 0.06 0.23 1.85 -0.16
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.25 -0.01 0.06 0.23 1.85 -0.16
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.90 -5.89 -5.95 -6.18 -8.76 -8.59
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.65 -5.90 -5.89 -5.95 -6.91 -8.76
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.21 -0.02 0.12 0.43 3.52 -0.31
Earnings Per Share(Adj)-Unit Curr 0.21 -0.02 - - - -
Book Value 10.60 -1.26 -1.24 -1.36 -1.79 -5.32
Book Value(Adj)-Unit Curr 10.60 -1.26 - - - -

Shareholding Pattern

  • Promoter Group

    10.46%

  • Public Share Holding

    89.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,212,025 10.46 1,020,625 106
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,212,025 10.46 1,020,625 106
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,432,680 12.37 1,328,580 52
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 262,243 2.26 1,543 301
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 65,103 0.56 65,103 31
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,826,093 58.93 6,476,093 36
Individuals holding nominal share capital up to Rs. 1 lakh 1,784,686 15.41 939,056 6,338
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 0 0.00 0 0
Sub Total 10,370,905 89.54 8,810,475 6,759
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,582,930 100.00 9,831,100 6,865

Company Background

Venmax Drugs & Pharmaceuticals LtdTrading

  • Venmax Drugs & Pharmaceuticals Ltd
  • BSE Code : 6161.0
  • ISIN : INE154G01022

  • Incorporation Year

    1988

  • Registered Office

    Sy No 115 Brig Sayeed Road
    Hanumanji Colony Old Bowenpall, Secunderabad,
    Telangana-500009

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Sadhanala Venkata Rao

  • Company Secretary

    Priyanka Agarwal

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Venmax Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venmax Drugs 13.99 8.19 8.02 73.63 2.28
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77